Tilray Brands, Inc.’s (NASDAQ:TLRY) (TSX:TLRY) medical cannabis division, Tilray Medical, has expanded its medical cannabis offerings in the United Kingdom.
Denise Faltischek, Tilray’s chief strategy officer, and head of international business, stated, “The demand for medical cannabis in the UK is growing rapidly. We are incredibly proud to provide patients in the UK with high-quality, consistent medical cannabis products they can rely on and are accessible to them.”
